Introduction
Myocardial bridging (MB) is a congenital coronary abnormality which is characterised with partial coverage of coronary artery by muscular tissue instead of adipose tissue during its epicardial course. 1 Myocardial bridge is most often detected in left anterior descending artery (LAD) and prevalence has been reported to be 0.4-5.4% on coronary angiography. 1 The main angiographic finding is systolic compression of the involved epicardial coronary artery. Diastolic f l o w d i s t u r b a n c e h a s b e e n d o c u m e n t e d b y intracoronary Doppler studies, and intravascular ultrasonography. 2, 3 Location, thickness and length of the muscle bridge are the main factors that influence the degree of coronary obstruction.
It has long been considered that patients with MB have relatively favourable long-term outcome. However, MB has the potential risks for acute coronary syndromes, coronar y spasm arrhythmias, exercise-induced atr ioventricula r co nduc tion blo cks, tra nsient ventricular dysfunction and sudden cardiac death. [4] [5] [6] [7] Therefore, the prognosis of patients with myocardial bridge, is not as benign as it was believed to be in the past.
In this repor t we present a potentially lethal complication of MB, acute anterior myocardial infarction.
Case
A 61-year-old woman presented to the emergency department with prolonged fever as a consequence of acute tonsillitis and retrosternal chest pain. Heart rate was 122 beats/minute and body temperature was 38.1°C. After reducing body temperature with in t r a ven o u s p a r a c e t a mo l ( Per f a lg a n ® , B M S ) , electrocardiogram detected ST segment elevation in leads V 2 to V 5 ( Figure 1 ). Subsequently, coronary angiography was performed for the diagnosis of acute anterior myocardial infarction. A myocardial bridge in the mid segment of left anterior descending artery leading to total occlusion of flow during systole was revealed ( Figure 2 ). During diastole the blood flow was resumed ( Figure 3 ). The patient was transferred to the cardiac care unit for observation a n d m e d i c a l t r e a t m e n t . S h e w a s g i v e n o r a l acetylsalicylic acid 300 mg/day, metoprolol 50 mg twice daily and parenteral amoxicillin/sulbactam for tonsillitis. Chest pain resolved after heart rate was reduced. Cardiac troponin-I value increased up to 2.85 ng/ml (normal range, <0.1 ng/ml). Transthoracic echocardiography revealed normal left ventricular functions and hypokinesia of apical segment of anterior wall. She was discharged a few days later with metoprolol 100 mg/day and acetylsalicylic acid 100 mg/day. Follow up for six months was uneventfull and wall motion abnormality of apical segment of anterior wall was fully recovered. 
Discussion
Myocardial bridging, an inborn abnormality, is defined as the presence of an intramyocardial segment of a major coronary artery that normally has an epicardial course. Myocardial bridge is reported in 0.4 to 5.4% of coronary angiograms and in 33% of autopsies. 1 In subjects with angiographically normal coronary arteries, the use of provocation tests may enhance systolic myocardial compression and thereby reveal myocardial bridges in 40% of cases. 8 Myocardial bridges are most commonly localised in the middle segment of the left anterior descending coronary artery (LAD). 9 They are located at a depth of 1 to 10 mm, with a typical length of 10 to 30 mm. 10 Dynamic compression has been thought to be caused by the compressing, overlying myocardium on the tunnelled segment.
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The typical angiographic finding of the MB is the systolic reduction of the epicardial coronary artery diameter and the persistence of this reduction during diastole. 12 Various clinical conditions such as myocardial ischaemia, arrhythmias and sudden death have been reported to be associated with myocardial bridging.
Neither nonsignificant stenosis proximal to the bridge nor systolic compression of the tunnelled segment alone can sufficiently result in severe ischaemia. 1 This case is an unusual presentation of mycardial bridge which resulted in acute myocardial infarction. Sinus tachycardia as a consequence of elevated body temperature was probably the leading cause of ischaemia in her. Reducing heart rate by decreasing body temperature and beta-blockers provided resolution of chest pain and ST segment elevation.
Drug therapy is the first-choice treatment for s y mp t o ma t ic p a t ien t s wit h MB . Dr u g b a s ed therapeutic approaches that have been attempted for MB include beta-blockers and calcium channel blockers. 13 Beta-blockers decrease tachycardia and increase diastolic time, with a decrease in contractility and compression of the coronary arteries. Nitrates generally should be avoided because they increase the angiographic degree of systolic narrowing and can lead to worsening of symptoms.
14 Surgical interventions are reserved for patients with angina that is refractor y to dr ug treatment. 15 Improvement in symptoms has been shown with stenting of the bridged segment. However, requirement of h ig h in flat io n press ures f or o pt imal s tent implanta tion brings ou t the risk of coronar y perforation. Surgical dissection of the myocardial fibres surrounding the myocardial bridge should be limited to patients with symptoms that persist despite medical treatment. 16 Good clinical results have been reported in a small series of these patients, although this type of procedure is extremely delicate and carries dangerous complications, including right and left ventricular perforation. Minimally invasive coronary artery bypass grafting has been reported for myocardial bridges.
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Conclusion
Myocardial bridging of major coronary arteries may present with various clinical conditions including acute myocardial infarction. Awareness of this clinical entity and administration of beta-blockers or calcium channel blockers for sinus tachycardia induced myocardial ischaemia may prevent further complications.
